Gastric Disease Clinical Trial
Official title:
The Effect of Oxygen Administration With Double Nasal Cannula on Respiratory Complications in Endoscopies
To compare desaturation and respiratory complications by applying oxygen therapy with double nasal cannula to patients who are planned to undergo gastrointestinal endoscopy.
Two groups of patients scheduled for gastrointestinal endoscopy will be compared in terms of desaturation and respiratory complications by applying 15 litres of oxygen therapy to the first group and 30 litres to the second group with double nasal cannula. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02105506 -
Safety and Feasibility of TachoSil®: Application on Esophageal Anastomoses
|
N/A | |
Completed |
NCT03198871 -
IV Acetaminophen for Post-Operative Pain Management in Enhanced Recovery After Surgery (ERAS) Population
|
Phase 4 | |
Not yet recruiting |
NCT06212206 -
PillBotâ„¢ - Remotely Controlled Capsule Endoscopy
|
N/A | |
Not yet recruiting |
NCT03092414 -
Linked Color Imaging Based CMV Diagnosis for Gastric Mucosal Lesions
|
N/A | |
Completed |
NCT03776916 -
Application of Simethicone in Esophagogastroscopy
|
N/A | |
Not yet recruiting |
NCT02994472 -
Gastric Emptying: in Vivo Studies in Healthy Volunteers
|
N/A | |
Recruiting |
NCT03267355 -
Indications and Outcomes of Endoscopic Ultrasound in Tanta
|
N/A | |
Completed |
NCT01322737 -
Feasibility Trial to Evaluate the Ability of the SuMO Tissue Access and Resection System
|
N/A | |
Completed |
NCT04111393 -
Transoral Removal of Specimen During Laparoscopic Gastric Resection
|
||
Recruiting |
NCT05249933 -
Pronase Granules in Gastric Cleaning
|
Phase 2/Phase 3 | |
Completed |
NCT04479423 -
The Usage of Soda-Water in Gastric Preparation for Magnetically Controlled Capsule Endoscopy
|
N/A | |
Completed |
NCT05392452 -
Fully Closed-Loop Insulin Delivery in Abdominal Surgery (CLAB)
|
N/A | |
Not yet recruiting |
NCT05801055 -
A Study to Evaluate Endoscopic Visibility of Stomach After a Combination Drink of N-acetylcysteine and Simethicone
|
Phase 3 |